BRPI9914031B8 - partículas micronizadas de sulfometato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição. - Google Patents

partículas micronizadas de sulfometato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição.

Info

Publication number
BRPI9914031B8
BRPI9914031B8 BRPI9914031A BRPI9914031A BRPI9914031B8 BR PI9914031 B8 BRPI9914031 B8 BR PI9914031B8 BR PI9914031 A BRPI9914031 A BR PI9914031A BR PI9914031 A BRPI9914031 A BR PI9914031A BR PI9914031 B8 BRPI9914031 B8 BR PI9914031B8
Authority
BR
Brazil
Prior art keywords
composition
sulfometate
capsule
particles
preparation
Prior art date
Application number
BRPI9914031A
Other languages
English (en)
Inventor
Richard Lovely James
Harris Goldman Martin
Anthony Flynn Richard
Original Assignee
Forest Laboratories Uk Ltd
Pharmax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10839350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI9914031(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Forest Laboratories Uk Ltd, Pharmax Ltd filed Critical Forest Laboratories Uk Ltd
Publication of BRPI9914031B8 publication Critical patent/BRPI9914031B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

patente de invenção: <b>"composições farmacêuticas micronizadas"<d>. são descritas composições farmacêuticas compreendendo sulfometato de sódio colistina micronizado. a substância farmacêutica micronizada pode ser usada em conjunto com um veículo, tal como lactose. as composições farmacêuticas podem ser embaladas em recipientes, tais como, cápsulas de gelatina, e administradas por inalação do pó.
BRPI9914031A 1998-09-23 1999-09-22 partículas micronizadas de sulfometato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição. BRPI9914031B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9820746.7A GB9820746D0 (en) 1998-09-23 1998-09-23 Micronised pharmaceutical compositions
PCT/GB1999/003172 WO2000016745A2 (en) 1998-09-23 1999-09-22 Micronised pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BRPI9914031B8 true BRPI9914031B8 (pt) 2019-02-26

Family

ID=10839350

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI9914031A BRPI9914031B8 (pt) 1998-09-23 1999-09-22 partículas micronizadas de sulfometato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição.
BRPI9914031-4A BR9914031B1 (pt) 1998-09-23 1999-09-22 partìculas micronizadas de sulfonetato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição.

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI9914031-4A BR9914031B1 (pt) 1998-09-23 1999-09-22 partìculas micronizadas de sulfonetato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição.

Country Status (20)

Country Link
EP (1) EP1115380B2 (pt)
JP (1) JP5165168B2 (pt)
CN (1) CN1148168C (pt)
AT (1) ATE267585T1 (pt)
AU (1) AU752266B2 (pt)
BR (2) BRPI9914031B8 (pt)
CA (1) CA2341366C (pt)
CZ (1) CZ298603B6 (pt)
DE (1) DE69917658T3 (pt)
DK (1) DK1115380T4 (pt)
EA (1) EA003193B1 (pt)
ES (1) ES2222733T5 (pt)
GB (1) GB9820746D0 (pt)
HU (1) HU228888B1 (pt)
IL (1) IL141913A0 (pt)
MX (1) MXPA01003103A (pt)
NZ (1) NZ509881A (pt)
PL (1) PL197871B1 (pt)
PT (1) PT1115380E (pt)
WO (1) WO2000016745A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129705A1 (en) * 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
WO2005053647A1 (en) * 2003-12-03 2005-06-16 Microdrug Ag Medical product containing tiotropium
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
WO2012061902A1 (en) * 2010-11-12 2012-05-18 Monash University Micronised spray-dried particles comprising polymyxin
US10441536B2 (en) * 2013-03-13 2019-10-15 Actavis Group Ptc Ehf Micronized colistimethane sodium pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579846A (en) * 1984-10-11 1986-04-01 Pfizer Inc. Antiinflammatory compositions and methods
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8911259D0 (en) 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament
US5916596A (en) 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US5875776A (en) 1996-04-09 1999-03-02 Vivorx Pharmaceuticals, Inc. Dry powder inhaler
EP0920324B1 (en) * 1996-11-15 2001-06-27 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections

Also Published As

Publication number Publication date
WO2000016745A2 (en) 2000-03-30
NZ509881A (en) 2003-01-31
CA2341366A1 (en) 2000-03-30
WO2000016745A3 (en) 2001-05-10
PL197871B1 (pl) 2008-05-30
DK1115380T3 (da) 2004-10-04
ATE267585T1 (de) 2004-06-15
CA2341366C (en) 2008-11-18
CZ20011050A3 (cs) 2001-09-12
ES2222733T5 (es) 2008-06-16
BR9914031A (pt) 2001-06-19
CZ298603B6 (cs) 2007-11-21
AU6212299A (en) 2000-04-10
PT1115380E (pt) 2004-10-29
PL346774A1 (en) 2002-02-25
EA200100253A1 (ru) 2001-08-27
DE69917658T3 (de) 2009-04-02
ES2222733T3 (es) 2005-02-01
DE69917658T2 (de) 2005-06-09
MXPA01003103A (es) 2005-02-17
HU228888B1 (en) 2013-06-28
JP2002526435A (ja) 2002-08-20
HUP0104928A2 (hu) 2002-04-29
AU752266B2 (en) 2002-09-12
IL141913A0 (en) 2002-03-10
DK1115380T4 (da) 2008-06-16
EP1115380B2 (en) 2008-03-12
CN1321082A (zh) 2001-11-07
EP1115380A2 (en) 2001-07-18
GB9820746D0 (en) 1998-11-18
DE69917658D1 (de) 2004-07-01
BR9914031B1 (pt) 2011-02-08
HUP0104928A3 (en) 2002-08-28
EA003193B1 (ru) 2003-02-27
EP1115380B1 (en) 2004-05-26
CN1148168C (zh) 2004-05-05
JP5165168B2 (ja) 2013-03-21

Similar Documents

Publication Publication Date Title
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
EP1049459A4 (en) ORAL LIQUID COMPOSITIONS
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
UA70942C2 (uk) Застосування n-заміщеного індоліл-3-гліоксиламіду як протипухлинного засобу, спосіб лікування пухлинних захворювань та лікарська композиція для лікування пухлинних захворювань
RU2014114221A (ru) Композиции и способы доставки фармакологических агентов
AR028504A2 (es) Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
BR0113539A (pt) Processo para a preparação de composições farmacêuticas para uso com formulações de gelatina macia
BR0211198A (pt) Composições farmacêuticas e seu uso
BR0008713A (pt) Processos para preparar formulações ecomposições farmacêuticas orais com ecb
TW200505436A (en) Modified release pharmaceutical compositions and the processes for preparing them
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
BRPI9914031B8 (pt) partículas micronizadas de sulfometato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição.
TW200517127A (en) Novel composition
DE69800210T2 (de) Wasserfreies Mittel auf Lactulosebasis
DK1061938T3 (da) Orale sammensætninger med cytotoksiske proteiner i lav dosis
MY133368A (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations
BR0008065A (pt) Derivados de colestano insaturados e seu uso para a preparação de medicamentos que regulam meiose